Clinical Core

Viruses R0 Our Friends

Concurrent Session Moderator(s)

• 

  David Porembka, DO, MCCM

  Professor of Anesthesia
  University of Maryland School of Medicine
  Baltimore, MD

  Disclosure(s): No relevant financial relationship(s) to disclose.
• JA

  John Allen, BCCCP, BCPS, PharmD (he/him/his)

  Associate Dean & Clinical Associate Professor
  University of Florida College of Pharmacy
  Orlando, Florida

  Disclosure(s): No relevant financial relationship(s) to disclose.

This session will cover the management of viruses in surge capacity situations. Appropriate identification, triage, management, and allocation of resources will be addressed, comprising three basic areas: 1) viruses that are considered common but that have pandemic potential (e.g., influenza), 2) vaccine-preventable viruses that have recently had resurgences (especially with declines in vaccination rates), and 3) viruses that are highly lethal in humans. This session will not focus on SARS-CoV-2 but will explore other viruses that clinicians may encounter in practice as demonstrated in recent history.

Presentations:

• When Flu Is New: Dealing With Epidemic or Pandemic Influenza in the ICU
  

  Concurrent Session Faculty: Marilyn N. Bulloch, PharmD, BCPS, SPP – Auburn University Harrison School of Pharmacy
• New(-ish) and Unfamiliar Viruses: When Scary Viruses Appear in the ICU
  

  Concurrent Session Faculty: Adrienne Randolph, MD, MS, FCCM – Boston Children's Hospital
• Resurgence of Old Viruses: Vaccine-Preventable Infections in the Critically Ill
  

  Concurrent Session Faculty: Ryan C. Maves, MD, FCCM – Wake Forest University School of Medicine